These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35419412)

  • 1. Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma.
    Zhang J; Zhang Q; Shi Y; Wang P; Gong Y; He S; Li Z; Feng N; Wang Y; Jiang P; Ci W; Li X; Zhou L
    Front Mol Biosci; 2022; 9():837145. PubMed ID: 35419412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
    Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
    Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
    Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
    BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma.
    Zhang K; Xu C; Liu S; Jiang Y; Zhao X; Ma S; Li Y; Yang F; Wang Y; Meng P; Shi C; Han D; Wen W; Qin W
    Front Oncol; 2021; 11():644612. PubMed ID: 33791227
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.
    Feng T; Zhao J; Wei D; Guo P; Yang X; Li Q; Fang Z; Wei Z; Li M; Jiang Y; Luo Y
    Front Immunol; 2021; 12():762120. PubMed ID: 34712244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism-associated molecular classification of hepatocellular carcinoma.
    Yang C; Huang X; Liu Z; Qin W; Wang C
    Mol Oncol; 2020 Apr; 14(4):896-913. PubMed ID: 31955511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma.
    Xu F; Guan Y; Xue L; Huang S; Gao K; Yang Z; Chong T
    BMC Cancer; 2020 Dec; 20(1):1207. PubMed ID: 33287763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma.
    Liu S; Cheng Y; Wang S; Liu H
    Front Mol Biosci; 2021; 8():747629. PubMed ID: 34977153
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
    Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
    Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy.
    Lai Y; Tang F; Huang Y; He C; Chen C; Zhao J; Wu W; He Z
    J Cell Physiol; 2021 Mar; 236(3):1616-1627. PubMed ID: 32783202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
    Tang C; Yu M; Ma J; Zhu Y
    J Transl Med; 2021 May; 19(1):205. PubMed ID: 33985530
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lin TC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
    Chen YL; Ge GJ; Qi C; Wang H; Wang HL; Li LY; Li GH; Xia LQ
    J Cell Physiol; 2018 Oct; 233(10):6649-6660. PubMed ID: 29327492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma.
    Zhang Z; Li Q; Wang F; Ma B; Meng Y; Zhang Q
    Front Genet; 2021; 12():606816. PubMed ID: 34194463
    [No Abstract]   [Full Text] [Related]  

  • 19. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
    Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.